Zentalis Pharmaceuticals Inc (ZNTL)
3.23
+0.05
(+1.57%)
USD |
NASDAQ |
Nov 22, 16:00
3.24
+0.01
(+0.31%)
After-Hours: 20:00
Zentalis Pharmaceuticals Enterprise Value: -161.06M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | -161.06M |
| November 21, 2024 | -164.63M |
| November 20, 2024 | -168.19M |
| November 19, 2024 | -178.17M |
| November 18, 2024 | -173.89M |
| November 15, 2024 | -143.96M |
| November 14, 2024 | -109.75M |
| November 13, 2024 | -111.89M |
| November 12, 2024 | -126.86M |
| November 11, 2024 | -104.05M |
| November 08, 2024 | -109.04M |
| November 07, 2024 | -119.73M |
| November 06, 2024 | -118.04M |
| November 05, 2024 | -122.31M |
| November 04, 2024 | -125.86M |
| November 01, 2024 | -155.04M |
| October 31, 2024 | -197.01M |
| October 30, 2024 | -199.15M |
| October 29, 2024 | -189.19M |
| October 28, 2024 | -189.90M |
| October 25, 2024 | -189.90M |
| October 24, 2024 | -170.69M |
| October 23, 2024 | -155.04M |
| October 22, 2024 | -169.26M |
| October 21, 2024 | -163.57M |
| Date | Value |
|---|---|
| October 18, 2024 | -167.84M |
| October 17, 2024 | -177.80M |
| October 16, 2024 | -179.23M |
| October 15, 2024 | -182.07M |
| October 14, 2024 | -180.65M |
| October 11, 2024 | -178.51M |
| October 10, 2024 | -182.07M |
| October 09, 2024 | -177.09M |
| October 08, 2024 | -174.96M |
| October 07, 2024 | -169.98M |
| October 04, 2024 | -151.48M |
| October 03, 2024 | -163.57M |
| October 02, 2024 | -152.90M |
| October 01, 2024 | -137.25M |
| September 30, 2024 | -129.42M |
| September 27, 2024 | 229.68M |
| September 26, 2024 | 225.41M |
| September 25, 2024 | 230.39M |
| September 24, 2024 | 248.88M |
| September 23, 2024 | 251.72M |
| September 20, 2024 | 263.10M |
| September 19, 2024 | 273.05M |
| September 18, 2024 | 258.83M |
| September 17, 2024 | 254.57M |
| September 16, 2024 | 224.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-199.15M
Minimum
Oct 30 2024
3.485B
Maximum
Dec 31 2021
1.205B
Average
1.103B
Median
Jun 06 2023
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -31.63M |
| Electromed Inc | 238.10M |
| Xtant Medical Holdings Inc | 83.10M |
| Myomo Inc | 147.33M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.16M |
| Total Expenses (Quarterly) | 51.43M |
| EPS Diluted (Quarterly) | -0.56 |
| Earnings Yield | -77.09% |